Search

everythinglearnresearchcommunity

for

Search:↓

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

The new assay can help develop products for hair re-growth.

A reliable method was developed to measure Finasteride and Tadalafil in rat blood.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

A mutation in the HR gene causes a rare form of irreversible hair loss in two Kashmiri families. Whole exome sequencing is effective for finding such mutations.

Adding a second method to PROTACs could improve cancer treatment.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Platelet-rich plasma is more effective and satisfactory than hyaluronic acid for knee osteoarthritis.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

No strong proof that platelet-rich plasma effectively treats hair loss.

PRP is a promising treatment for autoimmune hair loss but its exact workings are not fully understood.

Plaquenil can cause a severe skin reaction called AGEP, requiring prompt diagnosis and treatment.

Allergies, especially both seasonal and food, increase the risk of developing alopecia areata.

PLLA injections can cause hair loss and skin issues.

Platelet-rich plasma helps treat hair loss, and better screening improves transfusion safety.

PRFM may help treat hair loss, especially in mild cases.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

P2X₃-IR fibers are widespread in rat skin and likely help detect pain.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

Antiandrogens help improve developmental delays caused by valproic acid in rats.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.